TriSalus Life Sciences, Inc.
TLSIW- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001826667
No open-market purchases or sales by TriSalus Life Sciences, Inc. insiders were filed in the last 90 days; 5 institutions reported holding it in 13F filings for Q2 2026, worth $798.0K in total; no superinvestor holds it.
Other share classesTLSI
Q4 2025 vs. Q3 2025
How the institutions holding TriSalus Life Sciences, Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 4 | 8 | +4 |
| Shares | 213.9K | 1.07M | +854.5K (+399.5%) |
| Value | $337.4K | $1.77M | +$1.43M (+423.9%) |
New holders (5)
Institutions that held TriSalus Life Sciences, Inc. at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Cerity Partners LLC | 827,590 | $1.37M | 0.00% |
| Wolverine Asset Management LLC | 30,990 | $51.4K | 0.00% |
| Fort Baker Capital Management LP | 26,474 | $43.9K | 0.00% |
| Aristeia Capital LLC | 28,066 | $42.7K | 0.00% |
| Bank of America Corp | 1,009 | $1.68K | 0.00% |
Sold out (1)
Institutions that held TriSalus Life Sciences, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| B & T Capital Management DBA Alpha Capital Management | 11,000 | $18.7K |